{"transactions":[{"id":672243,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-08-31T20:57:34.000Z","date":"2026-08-31","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-26-000090","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/form4.xml","form_type":"4"}},{"id":672242,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-31T20:57:34.000Z","date":"2026-08-31","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":70.24,"value":702400.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/form4.xml","form_type":"4"}},{"id":672241,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-31T20:57:34.000Z","date":"2026-08-31","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":23.26,"value":232600.0,"ownership":{"direct":true},"balance_after":68555,"source":{"system":"sec-edgar","filing":"0001061983-26-000090","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000090/form4.xml","form_type":"4"}},{"id":700887,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-30T20:26:19.000Z","date":"2026-07-30","kind":"exercise","planned":true,"acquired":false,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":10000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001061983-26-000086","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000086/form4.xml","form_type":"4"}},{"id":700886,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:26:19.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":14000,"price":79.88,"value":1118320.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000086/form4.xml","form_type":"4"}},{"id":700885,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-30T20:26:19.000Z","date":"2026-07-30","kind":"exercise","planned":true,"acquired":true,"shares":14000,"price":23.26,"value":325640.0,"ownership":{"direct":true},"balance_after":72555,"source":{"system":"sec-edgar","filing":"0001061983-26-000086","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000086/form4.xml","form_type":"4"}},{"id":719052,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-07-02T21:19:20.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":24000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000073/form4.xml","form_type":"4"}},{"id":719051,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:19:20.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":85.8,"value":1287000.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000073/form4.xml","form_type":"4"}},{"id":719050,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-02T21:19:20.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":73555,"source":{"system":"sec-edgar","filing":"0001061983-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000073/form4.xml","form_type":"4"}},{"id":757669,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-06-01T22:51:44.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":39000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000065","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000065/form4.xml","form_type":"4"}},{"id":757668,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-01T22:51:44.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":74.08,"value":1111200.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000065/form4.xml","form_type":"4"}},{"id":757667,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-01T22:51:44.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":73555,"source":{"system":"sec-edgar","filing":"0001061983-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000065/form4.xml","form_type":"4"}},{"id":792529,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-05-05T20:11:18.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13070,"derivative":{"exercise_price":39.13,"exercise_date":"2023-04-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001061983-26-000047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000047/form4.xml","form_type":"4"}},{"id":792528,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:11:18.000Z","date":"2026-05-05","kind":"sale","planned":true,"acquired":false,"shares":11333,"price":77.25,"value":875474.25,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000047/form4.xml","form_type":"4"}},{"id":792527,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-05T20:11:18.000Z","date":"2026-05-05","kind":"exercise","planned":true,"acquired":true,"shares":11333,"price":39.13,"value":443460.29,"ownership":{"direct":true},"balance_after":69888,"source":{"system":"sec-edgar","filing":"0001061983-26-000047","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000047/form4.xml","form_type":"4"}},{"id":794399,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:01:28.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":15857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":0,"derivative":{"exercise_price":37.63,"exercise_date":"2025-04-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":15857},"source":{"system":"sec-edgar","filing":"0001061983-26-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000046/form4.xml","form_type":"4"}},{"id":794398,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:01:28.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":15857,"price":65,"value":1030705.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000046/form4.xml","form_type":"4"}},{"id":794397,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:01:28.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":15857,"price":37.63,"value":596698.91,"ownership":{"direct":true},"balance_after":74412,"source":{"system":"sec-edgar","filing":"0001061983-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000046/form4.xml","form_type":"4"}},{"id":797216,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-04-30T20:22:50.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":54000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000045","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000045/form4.xml","form_type":"4"}},{"id":797215,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-04-30T20:22:50.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":63.26,"value":948900.0,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000045/form4.xml","form_type":"4"}},{"id":797214,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-04-30T20:22:50.000Z","date":"2026-04-30","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":73555,"source":{"system":"sec-edgar","filing":"0001061983-26-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000045/form4.xml","form_type":"4"}},{"id":808340,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-04-15T21:29:09.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":7449,"price":66.02,"value":491782.98,"ownership":{"direct":true},"balance_after":58555,"source":{"system":"sec-edgar","filing":"0001061983-26-000036","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000036/form4.xml","form_type":"4"}},{"id":824514,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-31T20:21:08.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":3639,"price":65,"value":236535.0,"ownership":{"direct":true},"balance_after":66004,"source":{"system":"sec-edgar","filing":"0001061983-26-000030","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000030/form4.xml","form_type":"4"}},{"id":835723,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:43:50.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":2916,"price":62.15,"value":181229.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting."}],"balance_after":71573,"source":{"system":"sec-edgar","filing":"0001061983-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000028/form4.xml","form_type":"4"}},{"id":835722,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T21:43:50.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":5626,"price":62.15,"value":349655.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Company compelled sell-to-cover transaction to satisfy tax withholding obligations attributable to RSU vesting."}],"balance_after":74489,"source":{"system":"sec-edgar","filing":"0001061983-26-000028","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000028/form4.xml","form_type":"4"}},{"id":835717,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:55:25.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":1930,"price":62.07,"value":119795.1,"ownership":{"direct":true},"balance_after":78185,"source":{"system":"sec-edgar","filing":"0001061983-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000025/form4.xml","form_type":"4"}},{"id":839260,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-03-17T20:08:05.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":29480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":29480,"derivative":{"exercise_price":60.06,"exercise_date":"2026-04-15","expiration_date":"2036-03-14","underlying":"Common Stock","underlying_shares":29480},"source":{"system":"sec-edgar","filing":"0001061983-26-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000023/form4.xml","form_type":"4"}},{"id":839259,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-03-17T20:08:05.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":1665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":1665,"derivative":{"exercise_price":60.06,"exercise_date":"2026-04-15","expiration_date":"2036-03-14","underlying":"Common Stock","underlying_shares":1665},"source":{"system":"sec-edgar","filing":"0001061983-26-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000023/form4.xml","form_type":"4"}},{"id":839258,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:08:05.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":13320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Special supplemental equity award comprised of restricted stock units (\"RSUs\" that convert on a 1:1 basis for shares of our common stock. RSUs vest, subject to the officer's continued employment with the company, as follows: 50% of the RSUs on the 1-year anniversary of the grant date and 50% of the RSUs on the 2-year anniversary of the grant date. RSUs are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":81824,"source":{"system":"sec-edgar","filing":"0001061983-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000023/form4.xml","form_type":"4"}},{"id":839257,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:08:05.000Z","date":"2026-03-15","kind":"grant","planned":false,"acquired":true,"shares":20646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Annual equity award comprised of restricted stock units (\"RSUs\") that convert on a 1:1 basis for shares of our common stock. RSUs vest, subject to the officer's continued employment with the company, as follows: 40% of the RSUs on the 1-year anniversary of the grant date, an additional 40% of the RSUs on the 2-year anniversary of the grant date, and the final 20% of the RSUs on the 3-year anniversary of the grant date. RSUs are subject to the company's Amended and Restated 2004 Equity Incentive Plan."}],"balance_after":68504,"source":{"system":"sec-edgar","filing":"0001061983-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000023/form4.xml","form_type":"4"}},{"id":842389,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:14:19.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":1709,"price":61.03,"value":104300.27,"ownership":{"direct":true},"balance_after":46149,"source":{"system":"sec-edgar","filing":"0001061983-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000019/form4.xml","form_type":"4"}},{"id":851799,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-10T22:05:24.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":2582,"price":60.72,"value":156779.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell to cover transaction to satisfy company tax withholding obligations upon vesting of RSUs."}],"balance_after":47858,"source":{"system":"sec-edgar","filing":"0001061983-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000018/form4.xml","form_type":"4"}},{"id":859360,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-03-05T21:27:52.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":69000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000015/form4.xml","form_type":"4"}},{"id":859359,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-03-05T21:27:52.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24403,"derivative":{"exercise_price":39.13,"exercise_date":"2023-04-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001061983-26-000015","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000015/form4.xml","form_type":"4"}},{"id":859358,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:27:52.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":65440,"source":{"system":"sec-edgar","filing":"0001061983-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000015/form4.xml","form_type":"4"}},{"id":859357,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:27:52.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":61.88,"value":680680.0,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000015/form4.xml","form_type":"4"}},{"id":859356,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:27:52.000Z","date":"2026-03-05","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":61.87,"value":928050.0,"ownership":{"direct":true},"balance_after":61440,"source":{"system":"sec-edgar","filing":"0001061983-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000015/form4.xml","form_type":"4"}},{"id":859355,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-05T21:27:52.000Z","date":"2026-03-05","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":39.13,"value":430430.0,"ownership":{"direct":true},"balance_after":76440,"source":{"system":"sec-edgar","filing":"0001061983-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000015/form4.xml","form_type":"4"}},{"id":875140,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-03-02T21:28:06.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":0,"derivative":{"exercise_price":37.63,"exercise_date":"2025-04-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":886},"source":{"system":"sec-edgar","filing":"0001061983-26-000013","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000013/form4.xml","form_type":"4"}},{"id":875139,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:28:06.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":886,"price":61.62,"value":54595.32,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000013/form4.xml","form_type":"4"}},{"id":875138,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:28:06.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":886,"price":37.63,"value":33340.18,"ownership":{"direct":true},"balance_after":51326,"source":{"system":"sec-edgar","filing":"0001061983-26-000013","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000013/form4.xml","form_type":"4"}},{"id":918130,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-02-06T01:17:30.000Z","date":"2026-02-05","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":84000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000012/form4.xml","form_type":"4"}},{"id":918129,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T01:17:30.000Z","date":"2026-02-05","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":61.93,"value":928950.0,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000012/form4.xml","form_type":"4"}},{"id":918128,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-06T01:17:30.000Z","date":"2026-02-05","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":65440,"source":{"system":"sec-edgar","filing":"0001061983-26-000012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000012/form4.xml","form_type":"4"}},{"id":925691,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-02-02T21:40:38.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":false,"shares":886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant."}],"balance_after":886,"derivative":{"exercise_price":37.63,"exercise_date":"2025-04-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":886},"source":{"system":"sec-edgar","filing":"0001061983-26-000011","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000011/form4.xml","form_type":"4"}},{"id":925690,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-02T21:40:38.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":886,"price":62.1,"value":55020.6,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000011/form4.xml","form_type":"4"}},{"id":925689,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-02-02T21:40:38.000Z","date":"2026-02-02","kind":"exercise","planned":true,"acquired":true,"shares":886,"price":37.63,"value":33340.18,"ownership":{"direct":true},"balance_after":51326,"source":{"system":"sec-edgar","filing":"0001061983-26-000011","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000011/form4.xml","form_type":"4"}},{"id":953026,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2026-01-05T21:26:59.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-26-000002","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000002/form4.xml","form_type":"4"}},{"id":953025,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:26:59.000Z","date":"2026-01-05","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":60.28,"value":904200.0,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000002/form4.xml","form_type":"4"}},{"id":953024,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:26:59.000Z","date":"2026-01-05","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":65440,"source":{"system":"sec-edgar","filing":"0001061983-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000002/form4.xml","form_type":"4"}},{"id":955600,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2026-01-02T23:01:33.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":false,"shares":885,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1772,"derivative":{"exercise_price":37.63,"exercise_date":"2025-04-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":885},"source":{"system":"sec-edgar","filing":"0001061983-26-000001","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000001/form4.xml","form_type":"4"}},{"id":955599,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-02T23:01:33.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":885,"price":63.16,"value":55896.6,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000001/form4.xml","form_type":"4"}},{"id":955598,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-02T23:01:33.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":true,"shares":885,"price":37.63,"value":33302.55,"ownership":{"direct":true},"balance_after":51325,"source":{"system":"sec-edgar","filing":"0001061983-26-000001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000001/form4.xml","form_type":"4"}},{"id":955597,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-02T23:01:33.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":913,"price":62.09,"value":56688.17,"ownership":{"direct":true},"balance_after":50440,"source":{"system":"sec-edgar","filing":"0001061983-26-000001","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198326000001/form4.xml","form_type":"4"}},{"id":957551,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-30T21:34:40.000Z","date":"2025-12-29","kind":"sale","planned":true,"acquired":false,"shares":1809,"price":62.44,"value":112953.96,"ownership":{"direct":true},"balance_after":51353,"source":{"system":"sec-edgar","filing":"0001061983-25-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000057/form4.xml","form_type":"4"}},{"id":958756,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:04:58.000Z","date":"2025-12-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":675,"price":62.72,"value":42336.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Withholding of shares for tax withholding on vesting of performance shares."}],"balance_after":53162,"source":{"system":"sec-edgar","filing":"0001061983-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000054/form4.xml","form_type":"4"}},{"id":958755,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:04:58.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":1588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Performance shares earned upon achievement of performance goal. Shares remain subject to 1-year vesting requirement."}],"balance_after":53837,"source":{"system":"sec-edgar","filing":"0001061983-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000054/form4.xml","form_type":"4"}},{"id":958754,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-29T21:04:58.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":1589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Performance shares earned upon achieving performance goal. Shares vested immediately."}],"balance_after":52249,"source":{"system":"sec-edgar","filing":"0001061983-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000054/form4.xml","form_type":"4"}},{"id":978064,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-12-08T22:28:16.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35403,"derivative":{"exercise_price":39.13,"exercise_date":"2023-04-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001061983-25-000049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000049/form4.xml","form_type":"4"}},{"id":978063,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-08T22:28:16.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":1042,"price":65.96,"value":68730.32,"ownership":{"direct":true},"balance_after":50660,"source":{"system":"sec-edgar","filing":"0001061983-25-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000049/form4.xml","form_type":"4"}},{"id":978062,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-08T22:28:16.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":1042,"price":39.13,"value":40773.46,"ownership":{"direct":true},"balance_after":51702,"source":{"system":"sec-edgar","filing":"0001061983-25-000049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000049/form4.xml","form_type":"4"}},{"id":979445,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":10628,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2657,"derivative":{"exercise_price":37.63,"exercise_date":"2025-04-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":10628},"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979444,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":15858,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15857,"derivative":{"exercise_price":37.63,"exercise_date":"2025-04-01","expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":15858},"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979443,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36445,"derivative":{"exercise_price":39.13,"exercise_date":"2023-04-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979442,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":114000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979441,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"sale","planned":true,"acquired":false,"shares":52486,"price":65.95,"value":3461451.7,"ownership":{"direct":true},"balance_after":50660,"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979440,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":10628,"price":37.63,"value":399931.64,"ownership":{"direct":true},"balance_after":103146,"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979439,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":15858,"price":37.63,"value":596736.54,"ownership":{"direct":true},"balance_after":92518,"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979438,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":39.13,"value":430430.0,"ownership":{"direct":true},"balance_after":76660,"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979437,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T22:35:15.000Z","date":"2025-12-05","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":23.26,"value":348900.0,"ownership":{"direct":true},"balance_after":65660,"source":{"system":"sec-edgar","filing":"0001061983-25-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000048/form4.xml","form_type":"4"}},{"id":979436,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-05T21:23:02.000Z","date":"2025-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1368,"price":65.02,"value":88947.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell to cover transaction for tax withholding upon vesting of Performance Stock Units granted on March 14, 2024 and earned December 2, 2024."}],"balance_after":50660,"source":{"system":"sec-edgar","filing":"0001061983-25-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198325000045/form4.xml","form_type":"4"}},{"id":1121841,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-06-05T20:38:30.000Z","date":"2025-06-05","kind":"sale","planned":true,"acquired":false,"shares":8659,"price":32.04,"value":277434.36,"ownership":{"direct":true},"balance_after":52028,"source":{"system":"sec-edgar","filing":"0001127602-25-016865","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225016865/form4.xml","form_type":"4"}},{"id":1159857,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-05-05T22:21:57.000Z","date":"2025-05-05","kind":"sale","planned":true,"acquired":false,"shares":4002,"price":36.68,"value":146793.36,"ownership":{"direct":true},"balance_after":60687,"source":{"system":"sec-edgar","filing":"0001127602-25-013404","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225013404/form4.xml","form_type":"4"}},{"id":1176962,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-04-07T21:03:25.000Z","date":"2025-04-07","kind":"sale","planned":true,"acquired":false,"shares":2886,"price":35.78,"value":103261.08,"ownership":{"direct":true},"balance_after":64689,"source":{"system":"sec-edgar","filing":"0001127602-25-011767","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225011767/form4.xml","form_type":"4"}},{"id":1201559,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-03-18T20:20:45.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":47593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Callos's continued employment with the company on the scheduled vesting date."}],"balance_after":47593,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-13","underlying":"Common Stock","underlying_shares":47593},"source":{"system":"sec-edgar","filing":"0001127602-25-009765","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009765/form4.xml","form_type":"4"}},{"id":1201558,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2025-03-18T20:20:45.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":2749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Stock options vest in equal monthly installments over 48 months from the date of grant, subject to Mr. Callos's continued employment with the company on the scheduled vesting date."}],"balance_after":2749,"derivative":{"exercise_price":44.36,"exercise_date":"2025-04-14","expiration_date":"2035-03-14","underlying":"Common Stock","underlying_shares":2749},"source":{"system":"sec-edgar","filing":"0001127602-25-009765","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009765/form4.xml","form_type":"4"}},{"id":1201557,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T20:20:45.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":32687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that convert to shares of common stock on a 1:1 basis upon vesting. 40% of the RSUs will vest on the 1-year anniversary of the date of grant; an additional 40% of the RSUs will vest on the 2-year anniversary of the date of grant; and the final 20% of the RSUs will vest on the 3-year anniversary of the date of grant, in each case subject to Mr. Callos's continued employment with the company on the scheduled vesting date."}],"balance_after":70350,"source":{"system":"sec-edgar","filing":"0001127602-25-009765","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009765/form4.xml","form_type":"4"}},{"id":1204566,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-18T00:23:31.000Z","date":"2025-03-17","kind":"sale","planned":false,"acquired":false,"shares":2775,"price":44.38,"value":123154.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell to cover transaction in connection with the vesting of restricted stock units."}],"balance_after":34888,"source":{"system":"sec-edgar","filing":"0001127602-25-009712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009712/form4.xml","form_type":"4"}},{"id":1204562,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-03-17T20:33:26.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":false,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":129000,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001127602-25-009691","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009691/form4.xml","form_type":"4"}},{"id":1204561,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:33:26.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":20900,"price":45.14,"value":943426.0,"ownership":{"direct":true},"balance_after":37663,"source":{"system":"sec-edgar","filing":"0001127602-25-009691","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009691/form4.xml","form_type":"4"}},{"id":1204560,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:33:26.000Z","date":"2025-03-17","kind":"exercise","planned":true,"acquired":true,"shares":20900,"price":23.26,"value":486134.0,"ownership":{"direct":true},"balance_after":58563,"source":{"system":"sec-edgar","filing":"0001127602-25-009691","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009691/form4.xml","form_type":"4"}},{"id":1206347,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2025-03-15T00:53:44.000Z","date":"2025-03-14","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer."}],"balance_after":149900,"derivative":{"exercise_price":23.26,"exercise_date":"2022-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001127602-25-009556","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009556/form4.xml","form_type":"4"}},{"id":1206346,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-15T00:53:44.000Z","date":"2025-03-14","kind":"sale","planned":true,"acquired":false,"shares":100,"price":45,"value":4500.0,"ownership":{"direct":true},"balance_after":37663,"source":{"system":"sec-edgar","filing":"0001127602-25-009556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009556/form4.xml","form_type":"4"}},{"id":1206345,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-15T00:53:44.000Z","date":"2025-03-14","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":23.26,"value":2326.0,"ownership":{"direct":true},"balance_after":37763,"source":{"system":"sec-edgar","filing":"0001127602-25-009556","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009556/form4.xml","form_type":"4"}},{"id":1208248,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-13T20:30:11.000Z","date":"2025-03-13","kind":"sale","planned":true,"acquired":false,"shares":26771,"price":43.62,"value":1167751.02,"ownership":{"direct":true},"balance_after":37663,"source":{"system":"sec-edgar","filing":"0001127602-25-009355","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225009355/form4.xml","form_type":"4"}},{"id":1218156,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-08T01:43:42.000Z","date":"2025-03-06","kind":"sale","planned":false,"acquired":false,"shares":3341,"price":43.27,"value":144565.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale to cover transaction in connection with the vesting of restricted stock units."}],"balance_after":64434,"source":{"system":"sec-edgar","filing":"0001127602-25-008792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225008792/form4.xml","form_type":"4"}},{"id":1223867,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:37:10.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":1114,"price":42.88,"value":47768.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale to cover transaction in relation to vesting of restricted stock units."}],"balance_after":67775,"source":{"system":"sec-edgar","filing":"0001127602-25-008316","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760225008316/form4.xml","form_type":"4"}},{"id":1341894,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T21:22:21.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":3177,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction represents shares of PSUs whose performance condition was satisfied but that remain subject to time-based vesting.  These PSUs to vest in full December 3, 2025."}],"balance_after":68889,"source":{"system":"sec-edgar","filing":"0001127602-24-028713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224028713/form4.xml","form_type":"4"}},{"id":1341893,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T21:22:21.000Z","date":"2024-12-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1351,"price":51.51,"value":69590.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Transaction represents withholding of shares to satisfy grantee's tax obligations in connection with vesting PSUs."}],"balance_after":65712,"source":{"system":"sec-edgar","filing":"0001127602-24-028713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224028713/form4.xml","form_type":"4"}},{"id":1341892,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-05T21:22:21.000Z","date":"2024-12-03","kind":"grant","planned":false,"acquired":true,"shares":3176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents gross shares of common stock received by grantee upon vesting of Performance Stock Units (\"PSUs\")."}],"balance_after":67063,"source":{"system":"sec-edgar","filing":"0001127602-24-028713","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224028713/form4.xml","form_type":"4"}},{"id":1573259,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2024-03-18T23:02:42.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":1224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028."}],"balance_after":1224,"derivative":{"exercise_price":63.75,"exercise_date":"2024-04-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":1224},"source":{"system":"sec-edgar","filing":"0001127602-24-010517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224010517/form4.xml","form_type":"4"}},{"id":1573258,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2024-03-18T23:02:42.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":18346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 15, 2024, with the final installment vesting on March 14, 2028."}],"balance_after":18346,"derivative":{"exercise_price":63.75,"exercise_date":"2024-04-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":18346},"source":{"system":"sec-edgar","filing":"0001127602-24-010517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224010517/form4.xml","form_type":"4"}},{"id":1573257,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-18T23:02:42.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":16941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant."}],"balance_after":63887,"source":{"system":"sec-edgar","filing":"0001127602-24-010517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224010517/form4.xml","form_type":"4"}},{"id":1589797,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T21:18:49.000Z","date":"2024-03-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":5103,"price":66.88,"value":341288.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person."}],"balance_after":46946,"source":{"system":"sec-edgar","filing":"0001127602-24-009010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224009010/form4.xml","form_type":"4"}},{"id":1589796,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T21:18:49.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2202,"price":67.68,"value":149031.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units and does not represent a sale by the reporting person."}],"balance_after":52049,"source":{"system":"sec-edgar","filing":"0001127602-24-009010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224009010/form4.xml","form_type":"4"}},{"id":1966817,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-03-07T21:13:35.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":47445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027."}],"balance_after":47445,"derivative":{"exercise_price":39.13,"exercise_date":"2023-04-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":47445},"source":{"system":"sec-edgar","filing":"0001127602-23-009282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223009282/form4.xml","form_type":"4"}},{"id":1966816,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Incentive Stock Option (Right to Buy)","published_at":"2023-03-07T21:13:35.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":2555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027."}],"balance_after":2555,"derivative":{"exercise_price":39.13,"exercise_date":"2023-04-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":2555},"source":{"system":"sec-edgar","filing":"0001127602-23-009282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223009282/form4.xml","form_type":"4"}},{"id":1966815,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-07T21:13:35.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant."}],"balance_after":53683,"source":{"system":"sec-edgar","filing":"0001127602-23-009282","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223009282/form4.xml","form_type":"4"}},{"id":1975554,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-03T23:09:10.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":2202,"price":39.6,"value":87199.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 2, 2023 and does not represent a sale by the reporting person."}],"balance_after":23683,"source":{"system":"sec-edgar","filing":"0001127602-23-008853","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223008853/form4.xml","form_type":"4"}},{"id":2008698,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":18477,"kind":"person","name":"Callos Andrew","position":1,"cik":"0001852129","reported_name":"Callos Andrew","relationship":{"officer":true,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-02-17T22:43:50.000Z","date":"2023-02-16","kind":"tax_withholding","acquired":false,"shares":969,"price":44.13,"value":42761.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on February 16, 2023 and does not represent a sale by the reporting person."}],"balance_after":25885,"source":{"system":"sec-edgar","filing":"0001127602-23-005915","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223005915/form4.xml","form_type":"4"}}],"next_cursor":"2023-02-17T22:43:50.000000Z,2008698"}